CHRS Coherus Oncology, Inc. - Common Stock

NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗
$1,34
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026

Über Coherus Oncology, Inc. - Common Stock Unternehmensübersicht von Wikipedia

CHRS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$1.33
Marktkapitalisierung
$206M
P/E (TTM)
1.2
EPS (TTM)
$1.43
Umsatz (TTM)
$42M
Dividendenrendite
ROE
185.8%
Verschuldungsgrad
52W-Spanne
$1 – $3

CHRS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $42M
10-point trend, -77.8%
2016-12-31 2025-12-31
EPS $1.43
9-point trend, +131.9%
2017-12-31 2025-12-31
Freier Cashflow
8-point trend, +32.4%
2016-12-31 2023-12-31
Margen 398.4%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
CHRS
Peer-Median
P/E (TTM)
5-point trend, +123.7%
1.2
1.2
P/S (TTM) (K/V (TTM))
5-point trend, +8.5%
4.9
14.2
P/B (K/B)
5-point trend, -77.6%
3.4
1.2

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
CHRS
Peer-Median
Operating Margin (Betriebsgewinnmarge)
5-point trend, -431.6%
-429.5%
Net Profit Margin (Nettogewinnmarge)
5-point trend, +553.2%
398.4%
-1189.1%
ROA
5-point trend, +225.9%
47.5%
-58.9%
ROE
5-point trend, +173.9%
185.8%
-79.0%
ROIC
5-point trend, -647.6%
-296.9%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
CHRS
Peer-Median
Current Ratio (Liquiditätsgrad)
5-point trend, -59.6%
1.5
5.4
Quick Ratio
5-point trend, -58.6%
1.4

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
CHRS
Peer-Median
Revenue YoY (Umsatz YoY)
5-point trend, -87.1%
59.8%
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, -87.1%
-41.5%
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, -87.1%
-38.4%
EPS YoY (EPS VjV)
5-point trend, +137.5%
472.0%
Net Income YoY (Nettogewinn YoY)
5-point trend, +158.5%
489.4%

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
CHRS
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, +137.5%
$1.43

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
CHRS
Peer-Median

CHRS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 13 Analysten
  • Starker Kauf 5 38,5%
  • Kauf 6 46,2%
  • Halten 2 15,4%
  • Verkauf 0 0,0%
  • Starker Verkauf 0 0,0%

12-Monats-Kursziel

5 Analysten · 2026-08-15
Median-Ziel $7.00 +424,3%
Mittelwert-Ziel $7.40 +454,3%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
-0.01%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $-0.13 $-0.20 0.07%
31. März 2026 $-0.25 $-0.28 0.03%
31. Dezember 2025 $-0.34 $-0.35 0.01%
30. September 2025 $-0.33 $-0.33 0.00%
30. Juni 2025 $-0.34 $-0.30 -0.04%
31. März 2025 $-0.35 $-0.24 -0.11%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
CHRS $172M 1.0 59.8% 398.4% 185.8%
KRRO $75M -0.6 181.5% -1834.5% -140.8%
ABOS $128M -1.1 -129.4%
CUE $29M -1.1 195.8% -96.9% -119.3%
VYGR $232M -1.9 -49.5% -296.5% -54.4%
NKTX $131M -1.3 -31.1%
OKUR -0.7 -1733.7% -88.6%
CRBU $151M -1.0 11.7% -1327.4% -102.8%
CNTB $159M -2.8 -99.8% -86687.5% -97.9%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 17
Jährliche Gewinn- und Verlustrechnung-Daten für CHRS
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +35.6% $42M $26M $257M $211M $327M $476M $356M $0 $2M $190M $30M $31M
Cost of Revenue 7-point trend, -19.1% $14M $9M $159M $70M $58M $38M $17M · · · · ·
R&D Expense 12-point trend, +39.2% $109M $92M $109M $199M $363M $143M $94M $110M $162M $254M $213M $78M
SG&A Expense 12-point trend, +472.8% $101M $125M $192M $198M $170M $139M $137M $94M $71M $52M $36M $18M
Operating Expenses 12-point trend, +133.1% $223M $226M $460M $468M $590M $320M $248M $204M $234M $306M $249M $96M
Operating Income 12-point trend, -180.0% $-181M $-200M $-203M $-257M $-264M $156M $108M $-204M $-232M $-116M $-219M $-65M
Interest Expense 12-point trend, +130.8% $9M $11M $41M $32M $23M $21M $18M $10M $10M $8M $33.0K $4M
Interest Income 8-point trend, +400.0% $7M $4M $3M $2M $1M $600.0K $2M $1M · · · ·
Other Non-op 12-point trend, +137.7% $7M $8M $5M $4M $-283.0K $554.0K $3M $5M $3M $-4M $-5M $-19M
Pretax Income 9-point trend, +23.1% $-183M $-215M $-238M $-292M $-287M $136M $93M $-209M $-238M · · ·
Income Tax 12-point trend, +0.00 $0 $0 $-380.0K $0 $0 $3M $3M $0 $0 $0 $0 $0
Net Income 12-point trend, +292.8% $168M $29M $-238M $-292M $-287M $132M $90M $-209M $-238M $-127M $-223M $-87M
EPS (Basic) 9-point trend, +131.9% $1.43 $0.25 $-2.53 $-3.76 $-3.81 $1.85 $1.29 $-3.22 $-4.48 · · ·
EPS (Diluted) 9-point trend, +131.9% $1.43 $0.25 $-2.53 $-3.76 $-3.81 $1.62 $1.23 $-3.22 $-4.48 · · ·
Shares (Basic) 11-point trend, +1274.9% 117,143,457 114,553,537 94,162,637 77,630,020 75,449,632 71,411,705 69,679,916 65,034,827 53,133,620 · 37,125,617 8,520,100
Shares (Diluted) 9-point trend, +120.5% 117,143,457 114,553,537 94,162,637 77,630,020 75,449,632 83,491,898 73,185,943 65,034,827 53,133,620 · · ·
EBITDA 12-point trend, -181.0% $-180M $-110M $-200M $-257M $-264M $156M $108M $-204M $-232M $-116M $-219M $-64M
Bilanz 29
Jährliche Bilanz-Daten für CHRS
Kennzahl Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, -40.9% $89M $126M $103M $64M $417M $541M $178M $72M $127M $125M $158M $150M
Short-term Investments 5-point trend, +83246000.00 $83M · $15M $128M · · $0 $0 · · · ·
Receivables 11-point trend, +637.1% $18M $111M $261M $110M $123M $157M $142M $0 · $2M $2M $2M
Inventory 8-point trend, +91.2% $3M $4M $63M $39M $38M $44M $10M $2M · · · ·
Prepaid Expense 12-point trend, -69.6% $6M $10M $11M $23M $11M $6M $5M $2M $18M $32M $35M $20M
Other Current Assets 5-point trend, -96.4% · · · · · · · $83.0K $142.0K $3M $3M $2M
Current Assets 12-point trend, +15.4% $207M $342M $476M $381M $602M $767M $343M $84M $145M $161M $197M $179M
PP&E (Net) 12-point trend, -69.9% $1M $3M $5M $9M $8M $10M $6M $7M $13M $11M $11M $4M
PP&E (Gross) 6-point trend, +284.0% · · · · · · $22M $20M $23M $17M $14M $6M
Accum. Depreciation 9-point trend, +178.6% · · · $4M $4M $3M $16M $13M $10M $6M $4M $1M
Goodwill 10-point trend, +0.0% · · $943.0K $943.0K $900.0K $943.0K $943.0K $943.0K $943.0K $943.0K $943.0K $943.0K
Intangibles 12-point trend, +663.4% $20M $25M $42M $6M $4M $3M $3M $3M $3M $3M $3M $3M
Other Non-current Assets 12-point trend, +8006.0% $4M $6M $10M $9M $10M $13M $362.0K $14.0K $13.0K $2M $146.0K $50.0K
Total Assets 12-point trend, +38.0% $258M $449M $630M $481M $679M $842M $409M $99M $163M $178M $212M $187M
Accounts Payable 12-point trend, +13.0% $10M $28M $35M $12M $16M $15M $26M $15M $15M $20M $26M $9M
Accrued Liabilities 12-point trend, +81.9% $20M $60M $105M $50M $48M $27M $17M $7M $7M $28M $24M $11M
Current Liabilities 12-point trend, +171.1% $140M $283M $332M $139M $165M $146M $115M $33M $28M $56M $106M $52M
Capital Leases 8-point trend, +1457000.00 $1M $3M $5M $4M $7M $9M $10M $0 · · · ·
Deferred Tax Flat — no change across 3 periods $1M $1M $1M · · · · · · · · ·
Other Non-current Liabilities 12-point trend, +5632.6% $20M $29M $13M $3M $750.0K $1M $0 $2M $2M $2M $2M $347.0K
Total Liabilities 12-point trend, +63.8% $197M $581M $823M $618M $582M $561M $304M $138M $132M $159M $219M $120M
Long-term Debt 2-point trend, +73663000.00 · · · · · · $74M $0 · · · ·
Common Stock 12-point trend, +300.0% $12.0K $12.0K $11.0K $8.0K $7.0K $7.0K $7.0K $7.0K $6.0K $5.0K $4.0K $3.0K
Paid-in Capital 7-point trend, +44.3% $1.44B $1.42B $1.39B $1.20B $1.15B $1.04B $1.00B · · · · ·
Retained Earnings 12-point trend, -640.6% $-1.38B $-1.55B $-1.58B $-1.34B $-1.05B $-763M $-895M $-985M $-775M $-537M $-410M $-187M
AOCI 12-point trend, +62.9% $-195.0K $-275.0K $-248.0K $-249.0K $-270.0K $-270.0K $-558.0K $-282.0K $-750.0K $-630.0K $-401.0K $-525.0K
Stockholders' Equity 12-point trend, -8.7% $61M $-132M $-193M $-137M $98M $281M $105M $-39M $31M $19M $-6M $67M
Liabilities + Equity 12-point trend, +38.0% $258M $449M $630M $481M $679M $842M $409M $99M $163M $178M $212M $187M
Shares Outstanding 12-point trend, +264.3% 121,154,925 115,614,548 112,215,260 78,851,516 76,930,096 72,513,348 70,366,661 68,302,681 59,840,467 45,808,163 39,005,589 33,257,978
Cashflow 17
Jährliche Cashflow-Daten für CHRS
Kennzahl Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +92.9% $1M $2M $3M $4M $4M $3M $3M $3M $3M $3M $2M $674.0K
Stock-based Comp 12-point trend, +53.4% $17M $28M $43M $51M $51M $38M $34M $35M $33M $27M $17M $11M
Deferred Tax 4-point trend, -380000.00 · · $-380.0K · · · $0 $0 $0 · · ·
Amort. of Intangibles 2-point trend, -23.5% $3M $3M · · · · · · · · · ·
Restructuring · · · · · · · · $4M · · ·
Other Non-cash 4-point trend, -731.1% $-325M $-79M $17M · · · · · · · · $51M
Operating Cash Flow 12-point trend, -478.9% $-139M $-20M $-175M $-241M $-37M $154M $28M $-159M $-200M $-253M $-108M $-24M
CapEx 10-point trend, -90.0% · · $286.0K $2M $1M $7M $2M $789.0K $5M $7M $6M $3M
Investing Cash Flow 10-point trend, +5857.3% $375M $230M $145M $-167M $-138M $-14M $-13M $-1M $-4M $-7M · ·
Stock Issued 2-point trend, -96.4% · $1M · · $41M · · · · · · ·
Stock Repurchased · · · · · · · · · · · $2.0K
Net Stock Activity 2-point trend, +2045250.0% · · · · $41M · · · · · · $-2.0K
Financing Cash Flow 10-point trend, -221.0% $-274M $-187M $70M $54M $52M $224M $89M $105M $207M $226M · ·
Net Change in Cash 12-point trend, -133.5% $-37M $23M $39M $-354M $-124M $364M $105M $-55M $2M $-33M $8M $111M
Taxes Paid 8-point trend, +36000.00 $36.0K $-114.0K $-118.0K $40.0K $1M · $2M $0 $0 · · ·
Free Cash Flow 10-point trend, -554.2% · · $-175M $-243M $-39M $147M $27M $-160M $-205M $-259M $-114M $-27M
Levered FCF 5-point trend, -2372.3% · · $-216M $-276M $-62M $126M $9M · · · · ·
Rentabilität 7
Jährliche Rentabilität-Daten für CHRS
Kennzahl Trend 202520242023202220212020201920182017201620152014
Operating Margin 10-point trend, -106.6% -429.5% -41.8% -79.0% -121.7% -80.8% 32.9% · · -14918.8% -61.0% -729.2% -207.9%
Net Margin 10-point trend, +242.2% 398.4% 10.7% -92.5% -138.2% -87.9% 27.8% · · -15306.6% -67.0% -743.2% -280.1%
Pretax Margin 6-point trend, -1622.5% -434.2% 10.7% -92.6% -138.2% -87.9% 28.5% · · · · · ·
EBITDA Margin 10-point trend, -107.2% -426.4% -41.1% -77.8% -121.7% -80.8% 32.9% · · -14918.8% -61.0% -729.2% -205.8%
ROA 12-point trend, +164.0% 47.5% 5.3% -42.9% -50.3% -37.8% 21.1% 35.3% -159.8% -139.7% -65.2% -111.7% -74.3%
ROE 12-point trend, -67.7% 185.8% -25.9% 145.5% 248.8% -251.3% 49.3% 177.5% 1598.2% -930.7% -1778.5% -736.9% 575.6%
ROIC 6-point trend, -399.3% -296.9% · 104.9% 186.9% -270.0% 54.2% 99.2% · · · · ·
Liquidität & Solvenz 3
Jährliche Liquidität & Solvenz-Daten für CHRS
Kennzahl Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, -57.4% 1.5 1.2 1.4 2.7 3.6 5.3 3.0 2.5 5.1 2.9 1.9 3.5
Quick Ratio 12-point trend, -54.1% 1.4 0.8 1.1 2.2 3.3 4.8 2.8 2.2 4.5 2.2 1.5 3.0
Interest Coverage 12-point trend, -21.3% -20.1 -4.1 -5.0 -7.9 -11.5 7.4 6.1 -21.1 -24.3 -14.5 -6638.4 -16.6
Effizienz 3
Jährliche Effizienz-Daten für CHRS
Kennzahl Trend 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -55.0% 0.1 0.5 0.5 0.4 0.4 0.8 · 0.0 0.0 1.0 0.2 0.3
Inventory Turnover 6-point trend, +168.6% 3.7 1.8 3.1 1.8 1.4 1.4 · · · · · ·
Receivables Turnover 9-point trend, -97.2% 0.7 1.4 1.4 1.8 2.3 3.2 · · · 111.2 15.1 23.1
Pro Aktie 5
Jährliche Pro Aktie-Daten für CHRS
Kennzahl Trend 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, -74.9% $0.50 $-1.14 $-1.72 $-1.74 $1.27 $3.87 $1.50 $-0.56 $0.53 $0.53 $-0.19 $2.01
Revenue / Share 6-point trend, -93.7% $0.36 $2.32 $2.73 $2.72 $4.33 $5.70 · · · · · ·
Cash Flow / Share 7-point trend, -405.2% $-1.18 $-0.18 $-1.86 $-3.11 $-0.50 $1.85 $0.39 · · · · ·
Cash / Share 12-point trend, -83.8% $0.73 $1.09 $0.92 $0.81 $5.42 $7.46 $2.52 $1.06 $2.12 $3.20 $4.76 $4.52
EPS (TTM) 10-point trend, +141.7% $1.43 $0.25 $-2.53 $-3.76 $-3.81 $1.62 $1.23 $-3.22 $-4.48 $-3.43 · ·
Wachstumsraten 7
Jährliche Wachstumsraten-Daten für CHRS
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +290.7% 59.8% -89.7% 21.9% -35.4% -31.4% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -124.1% -41.5% -56.8% -18.5% · · · · · · · · ·
Revenue CAGR 5Y -38.4% · · · · · · · · · · ·
EPS YoY 472.0% · · · · · · · · · · ·
EPS CAGR 5Y -2.5% · · · · · · · · · · ·
Net Income YoY 489.4% · · · · · · · · · · ·
Net Income CAGR 5Y 4.9% · · · · · · · · · · ·
Bewertung (TTM) 10
Jährliche Bewertung (TTM)-Daten für CHRS
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +35.6% $42M $26M $257M $211M $327M $476M $356M $0 $2M $190M $30M $31M
Net Income TTM 12-point trend, +292.8% $168M $29M $-238M $-292M $-287M $132M $90M $-209M $-238M $-127M $-223M $-87M
Market Cap 12-point trend, -68.3% $172M $160M $374M $625M $1.23B $1.26B $1.27B $618M $527M $1.10B $764M $543M
P/E 10-point trend, +112.1% 1.0 5.5 -1.3 -2.1 -4.2 10.7 14.6 -2.8 -2.0 -8.2 · ·
P/S 11-point trend, -76.6% 4.1 6.0 1.5 3.0 3.8 2.6 3.6 · 338.4 5.8 25.4 17.4
P/B 12-point trend, -65.3% 2.8 -1.2 -1.9 -4.5 12.6 4.5 12.0 -16.0 16.5 53.5 -123.0 8.1
P / Tangible Book 3-point trend, -7.7% 4.2 · · · 13.2 4.5 · · · · · ·
P / Cash Flow 12-point trend, +94.5% -1.2 -7.8 -2.1 -2.6 -32.8 8.2 44.7 -3.9 -2.6 -4.3 -7.1 -22.7
P / FCF 10-point trend, +89.5% · · -2.1 -2.6 -31.7 8.6 47.8 -3.9 -2.6 -4.2 -6.7 -20.3
Earnings Yield 10-point trend, +926.8% 100.7% 18.1% -76.0% -47.5% -23.9% 9.3% 6.8% -35.6% -50.9% -12.2% · ·

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $42M$26M$257M$211M$327M
Betriebsgewinnmarge % -429.5%-41.8%-79.0%-121.7%-80.8%
Nettoergebnis $168M$29M$-238M$-292M$-287M
Verwässerte EPS $1.43$0.25$-2.53$-3.76$-3.81
Bilanz
2025-12-312024-12-312023-12-312022-12-312021-12-31
Liquiditätsgrad 1.51.21.42.73.6
Quick Ratio 1.40.81.12.23.3
Cashflow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Freier Cashflow $-175M$-243M$-39M

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 163 Einreicher · $56.1M gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
16 (-24 vs. Vorquartal) 19 (+12 vs. Vorquartal) 57 (+13 vs. Vorquartal) 42 (+4 vs. Vorquartal) +3.3M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
VANGUARD CAPITAL MANAGEMENT LLC $8.329.286 5.949.490 14,84% Aktien
SAMSARA BIOCAPITAL, LLC $4.799.999 3.428.571 8,55% Aktien
GEODE CAPITAL MANAGEMENT, LLC $4.430.615 3.163.856 7,89% Aktien
Kohlberg Kravis Roberts & Co. L.P. $4.184.019 3.036.076 7,45% Aktien
STATE STREET CORP $3.335.227 2.382.305 5,94% Aktien
TWO SIGMA INVESTMENTS, LP $3.163.177 2.259.412 5,64% Aktien
CM Management, LLC $2.940.000 2.100.000 5,24% Aktien
Alyeska Investment Group, L.P. $2.426.528 1.733.234 4,32% Aktien
Hudson Bay Capital Management LP $2.370.200 1.693.000 4,22% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $1.719.297 1.228.069 3,06% Aktien
PANAGORA ASSET MANAGEMENT INC $1.592.255 1.137.325 2,84% Aktien
VANGUARD FIDUCIARY TRUST CO $1.422.387 1.015.991 2,53% Aktien
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $1.260.000 899.999 2,24% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $1.236.836 883.454 2,20% Aktien
VANGUARD GROUP INC $1.076.153 757.854 1,92% Aktien
UBS Group AG $883.424 631.017 1,57% Aktien
BlackRock, Inc. $879.214 628.010 1,57% Aktien
RENAISSANCE TECHNOLOGIES LLC $788.278 563.056 1,40% Aktien
STRS OHIO $553.840 395.600 0,99% Aktien
BRIDGEWAY CAPITAL MANAGEMENT, LLC $547.400 391.000 0,98% Aktien
TWO SIGMA ADVISERS, LP $436.792 307.600 0,78% Aktien
BANK OF AMERICA CORP /DE/ $406.223 290.159 0,72% Aktien
ALLIANCEBERNSTEIN L.P. $375.011 221.900 0,67% Aktien
Jefferies Financial Group Inc. $352.800 252.000 0,63% Aktien
Tyche Wealth Partners LLC $281.683 201.202 0,50% Aktien
BARCLAYS PLC $272.575 194.696 0,49% Aktien
IEQ CAPITAL, LLC $227.294 162.353 0,40% Aktien
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main $223.986 159.990 0,40% Aktien
GOLDMAN SACHS GROUP INC $215.090 153.636 0,38% Aktien
RHUMBLINE ADVISERS $199.296 142.361 0,36% Aktien
ENVESTNET ASSET MANAGEMENT INC $197.218 140.870 0,35% Aktien
PVG ASSET MANAGEMENT CORP $186.529 133.235 0,33% Aktien
XTX Topco Ltd $172.896 123.497 0,31% Aktien
CITADEL ADVISORS LLC $162.120 115.800 0,29% Verkaufsoption
Summit Financial, LLC $160.805 114.861 0,29% Aktien
WELLS FARGO & COMPANY/MN $158.064 112.903 0,28% Aktien
Bank of New York Mellon Corp $153.657 109.755 0,27% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $153.478 109.627 0,27% Aktien
Shay Capital LLC $147.456 105.326 0,26% Aktien
Corient Private Wealth LP $140.000 100.000 0,25% Aktien
Nuveen Asset Management, LLC $131.177 95.056 0,23% Aktien
HSBC HOLDINGS PLC $130.950 91.895 0,23% Aktien
CWM, LLC $118.876 70.341 0,21% Aktien
MetLife Investment Management, LLC $110.058 78.613 0,20% Aktien
SEI INVESTMENTS CO $107.281 76.629 0,19% Aktien
Nuveen, LLC $107.281 76.629 0,19% Aktien
Headlands Technologies LLC $96.867 69.191 0,17% Aktien
SteelPeak Wealth, LLC $96.600 69.000 0,17% Aktien
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $95.873 62.255 0,17% Aktien
Squarepoint Ops LLC $92.613 66.152 0,17% Aktien
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $84.260 60.186 0,15% Aktien
Canton Hathaway, LLC $81.522 58.230 0,15% Aktien
Vanguard Global Advisers, LLC $80.933 57.809 0,14% Aktien
CITIGROUP INC $79.520 56.800 0,14% Aktien
JPMORGAN CHASE & CO $78.562 54.181 0,14% Aktien
Mariner, LLC $73.035 52.167 0,13% Aktien
Invesco Ltd. $72.390 51.707 0,13% Aktien
Russell Investments Group, Ltd. $70.858 50.613 0,13% Aktien
LPL Financial LLC $67.434 48.167 0,12% Aktien
WOLVERINE TRADING, LLC $66.810 39.300 0,12% Kaufoption
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC $61.860 42.958 0,11% Aktien
CITADEL ADVISORS LLC $58.736 41.954 0,10% Aktien
JANE STREET GROUP, LLC $54.128 38.663 0,10% Aktien
MANUFACTURERS LIFE INSURANCE COMPANY, THE $54.068 38.620 0,10% Aktien
WOLVERINE TRADING, LLC $51.612 30.360 0,09% Aktien
DIMENSIONAL FUND ADVISORS LP $49.556 35.397 0,09% Aktien
Carr Financial Group Corp $49.273 35.195 0,09% Aktien
Vanguard Personalized Indexing Management, LLC $46.410 33.150 0,08% Aktien
Cetera Investment Advisers $44.698 31.927 0,08% Aktien
INTECH INVESTMENT MANAGEMENT LLC $44.250 31.607 0,08% Aktien
Police & Firemen's Retirement System of New Jersey $39.522 28.230 0,07% Aktien
VOYA INVESTMENT MANAGEMENT LLC $38.713 27.652 0,07% Aktien
MERCER GLOBAL ADVISORS INC /ADV $37.212 26.580 0,07% Aktien
BNP PARIBAS FINANCIAL MARKETS $37.006 26.433 0,07% Aktien
Atria Investments, Inc $36.996 26.426 0,07% Aktien
China Universal Asset Management Co., Ltd. $34.369 24.549 0,06% Aktien
EntryPoint Capital, LLC $34.128 24.377 0,06% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $33.740 24.100 0,06% Verkaufsoption
ProShare Advisors LLC $31.040 22.172 0,06% Aktien
GROUP ONE TRADING LLC $29.184 20.846 0,05% Aktien
PRUDENTIAL FINANCIAL INC $29.169 20.835 0,05% Aktien
MILLENNIUM MANAGEMENT LLC $29.049 20.749 0,05% Aktien
NEW YORK STATE COMMON RETIREMENT FUND $28.830 20.593 0,05% Aktien
Tower Research Capital LLC (TRC) $28.819 20.585 0,05% Aktien
NORTHERN TRUST CORP $28.678 20.484 0,05% Aktien
Confluence Wealth Services, Inc. $27.725 19.803 0,05% Aktien
CAPTRUST FINANCIAL ADVISORS $26.340 18.814 0,05% Aktien
Spark Investment Management LLC $24.920 17.800 0,04% Aktien
CITADEL ADVISORS LLC $23.940 17.100 0,04% Kaufoption
Stratos Wealth Partners, LTD. $22.583 16.131 0,04% Aktien
Providence Wealth Advisors, LLC $21.975 15.000 0,04% Aktien
BOOTHBAY FUND MANAGEMENT, LLC $21.402 15.287 0,04% Aktien
Bronte Capital Management Pty Ltd. $21.367 15.262 0,04% Aktien
Medallion Wealth Advisors, LLC $21.000 15.000 0,04% Aktien
NEUBERGER BERMAN GROUP LLC $20.143 14.388 0,04% Aktien
Arax Advisory Partners $19.633 14.024 0,03% Aktien
Creative Planning $19.221 13.729 0,03% Aktien
Focus Partners Wealth $18.893 13.495 0,03% Aktien
VICTORY CAPITAL MANAGEMENT INC $18.796 13.426 0,03% Aktien
BRIGHTON JONES LLC $17.925 12.803 0,03% Aktien

Unternehmensinsider 25 Insider · 10 Führungskräfte · 14 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Dennis M Lanfear President & CEO 29. Mai 2026 A 125.017 0 0 $0
Bryan J Mcmichael Chief Financial Officer 29. Mai 2026 A 0 0 $0
Mcdavid Stilwell Chief Financial Officer 1. April 2023 F 102.252 0 0 $0
Jean-Frederic Viret Chief Financial Officer 18. Oktober 2019 S 6.385 0 0 $0
Vincent R Anicetti Chief Operating Officer 14. Oktober 2019 M 19.310 0 0 $0
Paul Reider Chief Commercial Officer 1. April 2023 F 87.053 0 0 $0
Vladimir Vexler Chief Scientific Officer 31. März 2023 F 116.361 0 0 $0
Barbara K Finck Chief Medical Officer 10. September 2018 M 37.043 0 0 $0
Peter K. Watler Chief Technical Officer 1. Februar 2018 A 5.900 0 0 $0
Alan C. Herman Chief Scientific Officer 15. Dezember 2017 A 50.460 0 0 $0
Michael Lee Ryan Direktor 5. Juni 2026 A 30.000 0 0 $0
Jill O'Donnell-Tormey Direktor 5. Juni 2026 A 30.000 0 0 $0
Charles W. Newton Direktor 5. Juni 2026 A 30.000 0 0 $0
Lee Nisley Newcomer Direktor 5. Juni 2026 A 30.000 0 0 $0
Ali J. Satvat Direktor 5. Juni 2026 A 30.000 0 0 $0
Rita A Karachun Direktor 5. Juni 2026 A 30.000 0 0 $0
Mats Wahlstrom Direktor 5. Juni 2026 A 30.000 0 0 $0
Dr. James I. Healy Direktor 29. September 2021 S 0 0 0 $0
Christos Richards Direktor 11. Januar 2019 A 63.836 0 0 $0
Mary T Szela Direktor 11. Januar 2019 A 0 0 $0
Bryan V Lawlis Direktor 11. Januar 2019 A 0 0 $0
Samuel R Nussbaum MD Direktor 11. Januar 2019 A 0 0 $0
August J. Troendle Direktor 1. Februar 2018 A 29.994 0 0 $0
FMR LLC 8. August 2016 S 361.594 0 0 $0
Daiichi Sankyo Company, LTD 12. November 2014 C 2.867.426 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 2 Beteiligungen

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
KKR BIOSIMILAR L.P., KKR BIOSIMILAR GP LLC, KKR FUND HOLDINGS L.P., KKR FUND HOLDINGS GP LIMITED, KKR GROUP HOLDINGS CORP., KKR & CO. INC., KKR MANAGEMENT LLC, HENRY R. KRAVIS, GEORGE R. ROBERTS ×3 Einreichungen 2. Dezember 2019 Erste Einreichung SEC
Sofinnova Venture Partners VII, L.P. (“SVP VII”), Sofinnova Management VII, L.L.C. (“SM VII”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Eric P. Buatois (“Buatois”) ×4 Einreichungen 14. Februar 2018 Erste Einreichung Passive Anlage SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 25 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
QQQS · Invesco Exchange-Traded Fund Trust … 0,39% 70.328 SH 8. August 2026 Täglich
IWC · iShares Trust 0,04% 448.096 SH 8. August 2026 Täglich
IBBQ · Invesco Exchange-Traded Fund Trust … 0,01% 8.309 SH 8. August 2026 Täglich
BIB · ProShares Trust 0,01% 5.525 NS 31. Mai 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 750.573 SH 8. August 2026 Täglich
VTWV · VANGUARD SCOTTSDALE FUNDS 0,01% 76.202 SH 8. August 2026 Täglich
PRFZ · Invesco Exchange-Traded Fund Trust 0,01% 210.316 SH 8. August 2026 Täglich
IWN · iShares Trust 0,01% 734.194 SH 8. August 2026 Täglich
RSSL · Global X Funds 0,01% 44.900 NS 30. April 2026 N-PORT
IWM · iShares Trust 0,00% 3.152.494 SH 8. August 2026 Täglich
SCHA · SCHWAB STRATEGIC TRUST 0,00% 709.098 NS 31. Mai 2026 N-PORT
ITWO · ProShares Trust 0,00% 4.874 NS 31. Mai 2026 N-PORT
IWO · iShares Trust 0,00% 426.176 SH 8. August 2026 Täglich
UWM · ProShares Trust 0,00% 3.812 NS 31. Mai 2026 N-PORT
URTY · ProShares Trust 0,00% 3.853 NS 31. Mai 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,00% 4.536 NS 31. Mai 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0,00% 14.072 NS 31. Mai 2026 N-PORT
HDG · ProShares Trust 0,00% 97 NS 31. Mai 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,00% 91.696 NS 31. Mai 2026 N-PORT
DFAS · Dimensional ETF Trust 0,00% 15.055 NS 30. April 2026 N-PORT
IWV · iShares Trust 0,00% 16.850 SH 8. August 2026 Täglich
VXF · VANGUARD INDEX FUNDS 0,00% 1.863.589 SH 8. August 2026 Täglich
VTI · VANGUARD INDEX FUNDS 0,00% 3.953.617 SH 8. August 2026 Täglich
VTWG · VANGUARD SCOTTSDALE FUNDS 0,00% 49.507 SH 8. August 2026 Täglich
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 7.172 SH 8. August 2026 Täglich